IPON Co., Ltd.
IPON is bringing a diverse set of technologies developed by government research institutions, universities and companies based in Korea.
- Novel Sulforaphane prodrugs for Idiopathic Pulmonary Fibrosis
- A first-in-class, single-strain live biotherapeutic product for CVD/CKD and Trimethylaminuria (ODD granted)
- CNS-penetrating Ghrelin Receptor Agonist for Brain & Skeletal Muscle Disorders
Address
DaejeonSouth Korea
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}